pharma · Myotonic Dystrophy type 1 and type 2 (DM1/DM2) · Non-Dystrophic Myotonias (NDM)
Lupin (Europe)
Lupin Europe GmbH
Lupin (Europe) trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.
EU HQ
37 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Employees
- 37
- Programs
- 4
- Drugs
- 9
- Patents
- 0
Lupin (Europe) clinical trials
Registry index of 4 ClinicalTrials.gov studies linked to Lupin (Europe) programs — each row shows trial ID, program name, phase, status, and indication.
Lupin (Europe) trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Lupin (Europe).
Trial registry
-
CTIS ↗ -
CTIS ↗ - 2024-513484-89-00CTIS ↗
MEX-NM-303
Myotonic disorders: Nondystrophic myotonias (NDM) or myotonic dystrophies (DM, type 1 or type 2)
-
CTIS ↗